Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA ApprovalBERKELEY ...

50 million Americans due for colon cancer screening avoid it because they consider traditional tests so unpleasant. But now it can be as simple as a blood test. If you’re overdue for your ...

Colorectal cancer (CRC) is the third most common cancer ... Task Force recommends that screening with stool DNA-FIT (sDNA-FIT) tests should be conducted once every one to three years starting ...

2. I’d never miss or delay colonoscopies and screening tests. Ponywang / Getty Images Cases of colorectal cancer have been rapidly increasing among young adults. Though the disease, which ...

Colon cancer rates are surging worldwide, especially among younger and relatively healthy people, making it more important ...

New Study Shows at-Home Colon Cancer Screening Test Reduces Risk of Colorectal Cancer Death, as Effective as Screening Colonoscopy July 25, 2024 — A noninvasive colorectal cancer screening test ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal cancer screening test, ColoAlert. The test leverages polymerase chain ...

Bowel cancer screening using a home kit called a faecal immunochemical test (FIT) is currently available for those aged 54 to ...

(DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert test. The stool-based test, utilizing polymerase chain reaction technology, detects colorectal ...